More Stories

Ultrasound-Guided Vascular Access

Vascular access complications are amongst the most common problems that negatively impact the outcomes of...

CLI Pre-Course: Extreme case — Rutherford Category IV Resting pain and Occluded Aorta

VIVA’s popular CLI Pre-Course features must-see cases from around the world. Each presenter walks attendees...

Late-Breaking Clinical Trial: Results of the Zilver PTX Post-Market Surveillance Study

The late-breaking clinical trials presented on the VIVA stage are advancing the specialty and affirming...

SFA Nitinol Stent Patient Level Meta-Analysis

Much more than a meeting, VIVA Physicians promotes research that encourages collaboration and ultimately delivers...

The Roundtable: Transition from Warfarin to TSOAC to LMWH to UFH

The Roundtable Spotlight: Transition from Warfarin to TSOAC to LMWH to UFH: Clarity Around the...

The Best Evidence for EndoVascular Therapy First for Patients with Critical Limb Ischemia

Critical Limb Ischemia (CLI) represents a complex pathologic state characterized by extensive and long-segment arterial...

Year in Review in Superficial Venous Disease with Dr. Kundu

VIVA Physicians welcomed The VEINS course to VIVA 15, doubling the options for attendees to...

Late-Breaking Clinical Trial: MAJESTIC Trial

16 Late-Breaking Clinical Trials were presented at VIVA 15 this year, demonstrating how the field...

Is Warfarin Still Relevant?

With the emergence of the novel oral anticoagulants (NOAC) as alternatives for warfarin has come...

Superb Registry 3 Year Data

Dr. Jaff: Welcome to VIVA365. I am Michael Jaff, joined by my colleagues: Gary Ansel,...